Altius Bioventures is a life science capital solutions provider with strong backing from strategic partners. We specialize in investing in, nurturing, and scaling the next generation of cutting-edge advanced therapy tools and technology startups. We focus on early-stage, founder-driven companies, offering them a highly engaged support ecosystem to guide them to their next valuation milestone. We specialize in startups that are pioneering advanced tools, technologies, consumables, software, and services in CGT manufacturing and have the potential to make treatments more affordable and accessible worldwide.
We commit our full resources to every investment, from pre-seed to Series A, building trust and aligning values with AT tools and technologies companies long before a collaboration begins. Our ongoing engagement enhances the potential for higher-value exits.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Vancouver, British Columbia , Ca
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- HQ
- Vancouver, British Columbia
Altius Bioventures Questions
Altius Bioventures's website is https://www.altiusbioventures.vc/
Altius Bioventures's LinkedIn profile is https://ca.linkedin.com/company/altius-bioventures
Altius Bioventures has
12 employees.
View email and phone details for 12
employees at Altius Bioventures.
Altius Bioventures's industry is
Venture Capital and Private Equity Principals
Altius Bioventures's top competitors are
Berkeley Skydeck,
Keli Therapeutics,
Artiva Biotherapeutics,
Discgenics,
Cellino,
Aseptuva,
Highmont Advisors,
Cell Therapy Group,
Ataraxia Partners,
Cell&gene Consulting Inc..
Altius Bioventures's categories are Venture Capital and Private Equity Principals
Altius Bioventures's founding year is 2024
